Login / Signup

Prevalence of osteonecrosis of the jaw and oral characteristics of oncologic patients treated with bisphosphonates at the General Hospital of Mexico.

María Verónica Cuevas-GonzálezCelia Minerva Díaz-AguirreEnrique Echevarría-Y-PérezJuan Carlos Cuevas González
Published in: Journal of the Korean Association of Oral and Maxillofacial Surgeons (2016)
A detailed intraoral assessment must be performed before initiating treatment with bisphosphonates to identify risk factors for osteonecrosis.
Keyphrases
  • healthcare
  • risk factors
  • prostate cancer
  • radical prostatectomy
  • combination therapy
  • adverse drug